Next Article in Journal
Intravitreal Injection of Long-Acting Pegylated Granulocyte Colony-Stimulating Factor Provides Neuroprotective Effects via Antioxidant Response in a Rat Model of Traumatic Optic Neuropathy
Next Article in Special Issue
Antioxidant and Cytoprotective Properties of Polyphenol-Rich Extracts from Antirhea borbonica and Doratoxylon apetalum against Atherogenic Lipids in Human Endothelial Cells
Previous Article in Journal
Multiomics Provide Insights into the Key Molecules and Pathways Involved in the Physiological Adaptation of Atlantic Salmon (Salmo salar) to Chemotherapeutic-Induced Oxidative Stress
Previous Article in Special Issue
UHPLC–MS/MS Analysis on Flavonoids Composition in Astragalus membranaceus and Their Antioxidant Activity
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

A Preliminary Study on the Effect of Hydrogen Gas on Alleviating Early CCl4-Induced Chronic Liver Injury in Rats

Department of Human Anatomy, Histology and Embryology, School of Basic Medical Sciences, Peking University, Beijing 100191, China
*
Authors to whom correspondence should be addressed.
These authors contributed equally to this work.
Antioxidants 2021, 10(12), 1933; https://doi.org/10.3390/antiox10121933
Submission received: 15 October 2021 / Revised: 28 November 2021 / Accepted: 30 November 2021 / Published: 1 December 2021
(This article belongs to the Special Issue Natural Products Targeting on Oxidative Stress-Related Diseases)

Abstract

:
As a small-molecule reductant substance, hydrogen gas has an obvious antioxidant function. It can selectively neutralize hydroxyl radicals (OH) and peroxynitrite (ONOO) in cells, reducing oxidative stress damage. The purpose of this study was to investigate the effect of hydrogen gas (3%) on early chronic liver injury (CLI) induced by CCl4 and to preliminarily explore the protective mechanism of hydrogen gas on hepatocytes by observing the expression of uncoupling protein 2 (UCP2) in liver tissue. Here, 32 rats were divided into four groups: the control group, CCl4 group, H2 (hydrogen gas) group, and CCl4 + H2 group. The effect of hydrogen gas on early CLI was observed by serological tests, ELISA, hematoxylin and eosin staining, and oil red O staining. Immunohistochemical staining and Western blotting were used to observe the expression of UCP2 in liver tissues. We found that CCl4 can induce significant steatosis in hepatocytes. When the hydrogen gas was inhaled, hepatocyte steatosis was reduced, and the UCP2 expression level in liver tissue was increased. These results suggest that hydrogen gas might upregulate UCP2 expression levels, reduce the generation of intracellular oxygen free radicals, affect lipid metabolism in liver cells, and play a protective role in liver cells.

1. Introduction

Chronic liver injury (CLI) is one of the main chronic diseases. With the improvement in living standards, the incidence of CLI has increased over the years and has seriously affected people’s health [1]. CLI has a series of obvious pathological characteristics, including liver steatosis, liver inflammation, cirrhosis, and liver cancer [2]. As an early stage in liver injury, hepatocyte steatosis refers to the occurrence of lipid droplets in the cytoplasm of liver cells beyond the normal physiological range or the appearance of lipid droplets in cells that do not typically contain fat [3]. Hepatocyte steatosis is a reversible disease, and early treatment has a good effect. However, if it is allowed to develop, it may eventually develop into cirrhosis.
Liver injury can be caused by a variety of endogenous and exogenous factors, such as alcohol, drugs, carbon tetrachloride (CCl4), and metabolic diseases [4]. CCl4 can cause liver cell damage through various mechanisms. Under the catalysis of cytochrome P450, CCl4 reacts with surrounding lipids and membrane proteins to generate halane free radicals, lipid free radicals (L), and protein free radicals (Pr) [5]. L and Pr also react with O2 to produce lipoalkoxy (LO), lipoperoxy (LOO), proteinaloxy (PrO), and proteinperoxy (PrOO) [6,7]. In addition, CCl4-induced lipid peroxidation products such as 4-HNE also induce the generation of intracellular hydrogen gas peroxide, and peroxides can produce hydroxyl groups under the catalysis of metal ions [8]. CCl4 generates various free radicals in a variety of ways. These free radicals can directly attack biological macromolecules in cells such as proteins, DNA, and lipids, causing serious damage to the body.
Hydrogen gas is the lightest known gas. It is colorless and odorless, with only 1/14 of the density of air [9]. Hydrogen gas has strong reducibility and is mainly used as a reducing agent in various industrial reactions to provide electrons to oxidizing substances [10]. In recent experimental studies, hydrogen gas has expanded its original range of applications and entered the medical field as a new antioxidant drug [11,12,13]. A variety of human diseases and the normal aging process of the body are closely related to oxygen free radicals produced by oxidative stress [14]. Hydrogen gas plays a therapeutic role in a variety of oxidative stress diseases, including cerebrovascular diseases [15], type 2 diabetes [16], sepsis [17], and so on.
Uncoupling proteins (UCPs) are a family of ion carriers located in the inner membrane of mitochondria that can mediate proton leakage and reduce the electrochemical gradient along the respiratory chain [18]. In mitochondria, the production of reactive oxide species (ROS) is sensitive to changes in proton dynamic potential energy in the inner membrane, and uncoupling protein-2 (UCP2) can disperse the mitochondrial inner membrane potential and pH gradient, thus reducing the production of ROS. This indicates that UCP2 has the ability to reduce intracellular oxidative stress [19]. However, whether UCP is involved in the oxidation resistance of hydrogen gas is unknown. Therefore, this study used CCl4 modeling to investigate the therapeutic effect of hydrogen gas on CLI and preliminarily to explore the protective mechanism of hydrogen gas on hepatocytes by observing the expression of UCP2 in liver tissues.

2. Materials and Methods

2.1. Rat Grouping and the Early CLI Model Construction

This study was approved by the Ethics Committee for Animal Research Studies at the Peking University Health Science Center (CXK 2016-0010). At least 3 days before the experiment, male Sprague–Dawley rats (250–300 g) were moved to the experimental environment for adaptive feeding, with light and darkness for 12 h each day and free drinking and eating.
Thirty-two rats were randomly divided into four groups: The control group, CCl4 group, CCl4 + H2 group, and H2 group. In the control and H2 groups, the rats received injections of olive oil on the first day and fifth day (olive oil was injected subcutaneously into the back at a dose of 30 μL/g body weight) and then untreated or treated with hydrogen gas. The rats in the CCl4 and CCl4 + H2 groups received injections of CCl4 (105033, Tongguang, China) (40% CCl4 in olive oil was injected subcutaneously into the back at a dose of 30 μL/g body weight) on the first day and fifth day. From the first day of the study, rats in the H2 and CCl4 + H2 groups inhaled high concentrations of hydrogen gas (QT13, Jinghui gas, Beijing, China) (3% hydrogen gas + 97% air) for 1 h every day for 7 consecutive days. Tissues were extracted on the eighth day after deep anesthesia with isoflurane.

2.2. Serological Index Detection

Blood was collected from the angular vein after deep anesthesia with isoflurane, stored at 4 °C for 30 min, then centrifuged at 4 °C and 2500 rpm for 20 min, and the supernatant was collected. Serological tests of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) were submitted to the Department of Laboratory Animal Science of Peking University Health Science Center, and the serological index test results are shown in Table 1 and Figure 1 as the mean ± SEM.

2.3. Histomorphological Observation

The livers were collected and fixed in 10% neutral buffered formalin for histological examination. For the best fixation effect, liver tissue samples of approximately 10 mm × 5 mm × 5 mm were used. Half of the fixed liver tissues in each group were dehydrated by gradient ethanol, transparent and embedded in paraffin. Paraffin-embedded sections were used for hematoxylin and eosin (H&E) staining. The other half of the fixed liver tissue was dehydrated by sucrose and embedded with optimal cutting temperature compound, and the subsequent sections were used for oil red O (ORO) staining. H&E staining and ORO staining were performed using standard procedures, and then, the samples were observed under a microscope (Olympus, Tokyo, Japan). For immunohistochemistry, liver tissue sections were incubated overnight with the primary antibody, followed by treatment with HistostainTM-plus kits (ZSGB-BIO, Beijing, China). The final stage of immunohistochemical staining was to display the antigen–antibody complexes using a DAB substrate kit. The primary antibody used in our study was anti-UCP2 (1:500, HPA075202, Sigma, St. Louis, MO, USA). Percentages of positive particles or areas visualized by microscopy were quantified by automated counting (ImageJ) on two or three fields of view selected randomly from each section. Two sections were selected from each group. The image capture was performed using a Leica DM5000 microscope.

2.4. Western Blotting

The liver tissues were lysed in cold RIPA buffer (Applygen, Beijing, China) for 15 min. The lysate was centrifuged at 12,000 rpm for 10 min at 4 °C. A 30 μL volume of protein was separated by SDS–PAGE gel. Then, the separated proteins were transferred to PVDF membranes and blocked in 5% skim milk (Harveybio, China) dissolved in Tris-buffered saline-Tween-20 (TBST) (Sinodetech, China) for 1 h at room temperature. The membrane was incubated with antibodies of goat anti-UCP2 (bs-20750R, Bioss, Beijing, China) and mouse anti-β actin (A2228, Sigma, St. Louis, MO, USA) overnight at 4 °C. Then, the membrane was incubated with horseradish peroxidase-conjugated anti-goat or anti-mouse IgG antibody (A5420, AP124P, Sigma, St. Louis, MO, USA) for 1 h at room temperature. The membrane was visualized using a superenhanced chemiluminescence reagent (ECL).

2.5. Enzyme-Linked Immunosorbent Assay (ELISA)

ELISA of interleukin-6 (IL-6), malondialdehyde (MDA), and superoxide dismutase (SOD) was performed according to the relevant kit instructions (Dogesce, Beijing, China).

2.6. Statistical Analysis

Data were expressed as the mean ± SEM. GraphPad Prism 6.0 (GraphPad, San Diego, CA, USA) was used for data analysis and statistical image processing. Multiple comparisons were statistically analyzed with one-way analysis of variance (ANOVA) followed by Tukey’s multiple comparison post hoc analysis. p < 0.05 was considered significant.

3. Results

3.1. Hydrogen Gas Inhalation Improved Liver Function in CLI

The serum ALT and AST levels in the CCl4 group were significantly increased compared with those in the control group (p < 0.05, Figure 1a,b, Table 1). After hydrogen gas inhalation, the ALT and AST levels in the CCl4 + H2 group were significantly lower than those in the CCl4 group (p < 0.05, Figure 1a,b, Table 1). There was no significant difference between the H2 group and the control group (p ≥ 0.05, Figure 1a,b, Table 1). These results indicated that hydrogen gas inhalation could improve liver function in CLI. However, hydrogen gas did not affect the liver function of healthy rats.

3.2. Hydrogen Gas Inhalation Reduced CCl4-Induced Inflammation

The expression of IL-6, an inflammatory factor, in the CCl4 group was significantly higher than that in the control group (p < 0.05, Figure 2). After inhaling hydrogen, this index decreased significantly (p < 0.05, Figure 2), but there was no difference between the H2 group and the control group (p ≥ 0.05, Figure 2). These results confirmed that hydrogen gas inhalation could reduce the inflammation induced by CCl4.

3.3. Hydrogen Gas Inhalation Reduced CCl4-Induced Hepatocyte Steatosis

H&E staining of liver tissue from the control group showed that the structure of the hepatic lobules was clear and that the hepatocytes were radially arranged around the central vein in normal hepatic lobules with clear nuclei and uniform cytoplasm (Figure 3a,b). However, in liver tissue from the CCl4 group, the lobular structure was disordered, fat degeneration in liver cells was observed, and the nucleus was pushed to one side (Figure 3c,d). The hepatic lobule structure of the H2 group was essentially the same as that of the control group (Figure 3g,h). However, the hepatic lobule structure in the CCl4 + H2 group was clearer than that in the CCl4 group, and more orderly liver cells had a less vacuolar structure (Figure 3e,f). Statistical data showed that the CCl4 group had a higher nonalcoholic steatohepatitis (NASH) activity score than the control group, but this score was significantly lower in the CCl4 + H2 group than that in the CCl4 group (Figure 4).
ORO staining showed that there was no red droplet deposition in the cytoplasm in the control group (Figure 5a,b). However, numerous bright red droplets of different sizes were observed in the CCl4 group. The nuclei, which were stained blue, were forced towards the edge by red particles (Figure 5c,d), and there was no red droplet deposition in the cytoplasm of liver cells in the H2 group (Figure 5g,h). The CCl4 + H2 group showed a significant reduction in red lipid droplets compared to the CCl4 group (Figure 5e,f). Statistical data showed that the ORO positive area in the CCl4 group was significantly increased compared with the control group, but the CCl4 + H2 group showed a downward trend (Figure 6).
These results suggest that hydrogen gas inhalation can significantly improve the structure of hepatic lobules and reduce the accumulation of fat in hepatic cells. However, it has no effect on the morphology of the liver in healthy rats.

3.4. Hydrogen Gas Inhalation Reduced CCl4-Induced Oxidative Stress

MDA, an end product of membrane lipid peroxidation, reflects the degree of tissue peroxidation damage [20]. The CCl4 group showed significantly higher levels than the control group (p < 0.05, Figure 7a). The level of MDA in the CCl4 + H2 group was decreased compared with that in the CCl4 group, and the difference was statistically significant (p < 0.05, Figure 7a). SOD, a major antioxidant enzyme in the body’s oxidative stress response, reflects the ability of tissue to resist oxidative damage [20]. The change in enzyme activities was shown in Figure 7b. The activity in the CCl4 group was significantly lower than that in the control group (p < 0.05). The enzyme activity of SOD in the CCl4 + H2 group was higher than that in the CCl4 group (p < 0.05, Figure 7b). These results suggest that CCl4 can induce oxidative stress in rat liver.

3.5. Inha lation of Hydrogen Gas Increased UCP2 Expression in Hepatocytes

Immunohistochemical staining showed different amounts of brownish-yellow UCP2 particles in the liver tissues of the control group, CCl4 group, H2 group, and CCl4 + H2 group. A small number of UCP2-positive cells were found in the liver tissues of the control group and CCl4 group (Figure 8a–d). The number of UCP2-positive cells in the H2 group was significantly higher than that in the control group, and the brown-yellow substances were evenly distributed in the cytoplasm (p < 0.05, Figure 8a,b,g,h and Figure 9). UCP2 was diffusely expressed in the liver tissues of the CCl4 + H2 group. It was mostly located on the side of the cell membrane, presenting a dotted and linear distribution (Figure 8e,f). There were significantly more UCP2 positive particles in the CCl4 + H2 group than those in the CCl4 group (p < 0.05, Figure 9).
Western blotting results showed that UCP2 expression (UCP2/β-action relative optical density) in liver tissues of the control group, CCl4 group, CCl4 + H2 group, and H2 group was 0.21 ± 0.17, 0.46 ± 0.22, 0.63 ± 0.19, and 0.68 ± 0.15, respectively. The H2 and CCl4 + H2 groups were significantly different from the control group (p < 0.05, Figure 10). These results suggest that hydrogen gas may promote the expression of UCP2 in hepatocytes.

4. Discussion

CLI has the characteristics of a series of obvious pathological changes, including hepatocyte steatosis, liver inflammation, cirrhosis, and liver cancer, among which hepatocyte steatosis is an early symptom of liver injury [2]. Early treatment can have a good effect, but if left untreated, it will eventually become irreversible liver cirrhosis. CCl4 can increase the synthesis of fatty acids and triglycerides and promote lipid peroxidation. Thus, it can reduce the secretion of VLDL in liver cells and lead to lipid transport disorders [7]. Therefore, we established an early CLI model by subcutaneous injection of CCl4 into the back. Both H&E staining and ORO staining showed obvious damage to liver lobules and fat accumulation in liver cells, which demonstrated the success of the model construction. Compared with most current methods of CCl4-induced CLI [21], this experiment shortened the modeling time. Therefore, this model produced steatosis without fibrosis, to study the therapeutic effect of hydrogen gas on early CLI.
Many studies have shown that hydrogen gas, as a new type of antioxidant, plays a therapeutic role in various oxidative stress diseases [22,23,24]. Hydrogen gas can exert a protective effect against liver ischemia–reperfusion combined with resection injury [25]. In our study, inhalation of a high concentration of hydrogen gas (3%) was used to treat CCl4-induced hepatic steatosis. The results showed that inhaling a high concentration of hydrogen gas could significantly reduce the content of ALT and AST in serum and improve hepatic steatosis. These results are probably related to its antioxidant effect. In cultured cells, hydrogen gas reacts directly and selectively with the most oxidizing oxygen radical, OH [12]. Hydrogen gas also reacts with ONOO in cell-free systems. Two free radicals, OH and ONOO, play a key role in CCl4-induced liver injury [26]. On the one hand, hydrogen gas effectively combats the damage caused by oxidative stress in the body. On the other hand, according to the study of Ohsawa I et al. [12], hydrogen gas does not react with some oxygen radicals with weak oxidation capacity in the body, such as O2▪−, H2O2▪−, NO, NAD+, FAD+, and oxidized vitamin C. These oxidizing free radicals have very important signal transduction functions in the cell. Hydrogen gas rarely affects the normal metabolism of the body and normal physiological parameters of the human body, such as body temperature, blood pressure, pH of body fluid, and blood oxygen partial pressure. We also found that inhalation of hydrogen gas did not affect liver function or liver morphology in healthy rats.
UCPs are a family of ionophores located in the inner membrane of mitochondria. They mediate proton leakage and thus reduce the electrochemical gradient along the respiratory chain [18]. UCP2 is closely related to the production of oxygen free radicals. In mitochondria, ROS production is sensitive to changes in proton dynamic potential energy in the inner membrane, while UCP2 can disperse the mitochondrial inner membrane potential and pH gradient to reduce ROS production, indicating that UCP2 has the ability to reduce intracellular oxidative stress [18]. UCP2 is involved in a wide range of physiological and pathological processes in vivo, including cell protection [27], immune cell regulation [28], and glucose sensitivity regulation [29] in the brain and pancreas. A growing number of studies have shown that UCP2 plays a protective role in various tissues by reducing the level of oxidative stress in cells, which is an important indicator of the potential relationship between hydrogen gas and UCP2 [28,30,31]. In our study, hepatocyte steatosis induced by CCl4 was treated with hydrogen gas. UCP2 expression was observed in all groups. However, the expression of UCP2 in the H2 group was significantly enhanced compared with that in the groups without hydrogen gas, suggesting that hydrogen gas may promote the expression of UCP2 in cells. UCP2, as a phosphate dissolve coupling protein, can regulate ATP production in vivo and affect the energy metabolism system of cells [32]. The effects of elevated UCP2 are a double-edged sword. On the one hand, it can relieve oxidative stress in the body and play a protective role in the body. On the other hand, although the high expression of UCP2 does not affect the liver function and liver morphology of healthy rats in our study, it should not be ignored that UCP2 can reduce the potential level of the respiratory chain, reduce the power of electron transfer, and lead to reduced ATP production.

5. Conclusions

Hydrogen gas can upregulate UCP2 expression levels, reduce the generation of intracellular oxygen free radicals, affect lipid metabolism in liver cells, and play a protective role in liver cells.

Author Contributions

Conceptualization, W.Z. and C.C.; methodology, J.W. and Q.C.; data analysis, J.W. and Q.C.; investigation, J.F.; data curation, H.D. and H.L.; writing—original draft preparation, Q.C.; writing—review and editing, J.W.; visualization, X.F.; funding acquisition, W.Z. and C.C. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the National Natural Science Foundation of China, Grant Number: 81873769 and the Beijing Municipal Natural Science Foundation, Grant Number: 7162098.

Institutional Review Board Statement

The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Institutional Review Board of Peking University (Protocol Code: LA2017100).

Informed Consent Statement

Not applicable.

Data Availability Statement

The data presented in this study are available in this manuscript.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Asrani, S.K.; Devarbhavi, H.; Eaton, J.; Kamath, P.S. Burden of liver diseases in the world. J. Hepatol. 2019, 70, 151–171. [Google Scholar] [CrossRef] [PubMed]
  2. Baker, S.S.; Baker, R.D. Gut Microbiota and Liver Injury (II): Chronic Liver Injury. Adv. Exp. Med. Biol. 2020, 1238, 39–54. [Google Scholar] [CrossRef] [PubMed]
  3. Gluchowski, N.L.; Gabriel, K.R.; Chitraju, C.; Bronson, R.T.; Mejhert, N.; Boland, S.; Wang, K.; Lai, Z.W.; Farese, R.V., Jr.; Walther, T.C. Hepatocyte Deletion of Triglyceride-Synthesis Enzyme Acyl CoA: Diacylglycerol Acyltransferase 2 Reduces Steatosis Without Increasing Inflammation or Fibrosis in Mice. Hepatology 2019, 70, 1972–1985. [Google Scholar] [CrossRef] [PubMed]
  4. Xiao, J.; Wang, F.; Wong, N.K.; He, J.; Zhang, R.; Sun, R.; Xu, Y.; Liu, Y.; Li, W.; Koike, K.; et al. Global liver disease burdens and research trends: Analysis from a Chinese perspective. J. Hepatol. 2019, 71, 212–221. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  5. Unsal, V.; Cicek, M.; Sabancilar, I. Toxicity of carbon tetrachloride, free radicals and role of antioxidants. Rev. Environ. Health 2020, 36, 279–295. [Google Scholar] [CrossRef] [PubMed]
  6. Thomas, C.E.; Aust, S.D. Free radicals and environmental toxins. Ann. Emerg. Med. 1986, 15, 1075–1083. [Google Scholar] [CrossRef]
  7. El-Hadary, A.E.; Ramadan Hassanien, M.F. Hepatoprotective effect of cold-pressed Syzygium aromaticum oil against carbon tetrachloride (CCl4)-induced hepatotoxicity in rats. Pharm. Biol. 2016, 54, 1364–1372. [Google Scholar] [CrossRef] [Green Version]
  8. Xiao, M.; Zhong, H.; Xia, L.; Tao, Y.; Yin, H. Pathophysiology of mitochondrial lipid oxidation: Role of 4-hydroxynonenal (4-HNE) and other bioactive lipids in mitochondria. Free Radic. Biol. Med. 2017, 111, 316–327. [Google Scholar] [CrossRef]
  9. Huang, C.S.; Kawamura, T.; Toyoda, Y.; Nakao, A. Recent advances in hydrogen research as a therapeutic medical gas. Free Radic. Res. 2010, 44, 971–982. [Google Scholar] [CrossRef]
  10. Preuster, P.; Alekseev, A.; Wasserscheid, P. Hydrogen Storage Technologies for Future Energy Systems. Annu. Rev. Chem. Biomol. Eng. 2017, 8, 445–471. [Google Scholar] [CrossRef] [PubMed]
  11. Xie, K.; Yu, Y.; Pei, Y.; Hou, L.; Chen, S.; Xiong, L.; Wang, G. Protective effects of hydrogen gas on murine polymicrobial sepsis via reducing oxidative stress and HMGB1 release. Shock 2010, 34, 90–97. [Google Scholar] [CrossRef] [Green Version]
  12. Ohsawa, I.; Ishikawa, M.; Takahashi, K.; Watanabe, M.; Nishimaki, K.; Yamagata, K.; Katsura, K.; Katayama, Y.; Asoh, S.; Ohta, S. Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals. Nat. Med. 2007, 13, 688–694. [Google Scholar] [CrossRef]
  13. Meng, X.; Chen, H.; Wang, G.; Yu, Y.; Xie, K. Hydrogen-rich saline attenuates chemotherapy-induced ovarian injury via regulation of oxidative stress. Exp. Ther. Med. 2015, 10, 2277–2282. [Google Scholar] [CrossRef] [Green Version]
  14. Filomeni, G.; De Zio, D.; Cecconi, F. Oxidative stress and autophagy: The clash between damage and metabolic needs. Cell Death Differ. 2015, 22, 377–388. [Google Scholar] [CrossRef] [Green Version]
  15. Iketani, M.; Ohsawa, I. Molecular Hydrogen as a Neuroprotective Agent. Curr. Neuropharmacol. 2017, 15, 324–331. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  16. Zhang, X.; Liu, J.; Jin, K.; Xu, H.; Wang, C.; Zhang, Z.; Kong, M.; Zhang, Z.; Wang, Q.; Wang, F. Subcutaneous injection of hydrogen gas is a novel effective treatment for type 2 diabetes. J. Diabetes Investig. 2018, 9, 83–90. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  17. Yu, Y.; Yang, Y.; Bian, Y.; Li, Y.; Liu, L.; Zhang, H.; Xie, K.; Wang, G.; Yu, Y. Hydrogen Gas Protects Against Intestinal Injury in Wild Type But Not NRF2 Knockout Mice With Severe Sepsis by Regulating HO-1 and HMGB1 Release. Shock 2017, 48, 364–370. [Google Scholar] [CrossRef] [PubMed]
  18. Sreedhar, A.; Zhao, Y. Uncoupling protein 2 and metabolic diseases. Mitochondrion 2017, 34, 135–140. [Google Scholar] [CrossRef] [Green Version]
  19. Zhong, X.; He, J.; Zhang, X.; Li, C.; Tian, X.; Xia, W.; Gan, H.; Xia, Y. UCP2 alleviates tubular epithelial cell apoptosis in lipopolysaccharide-induced acute kidney injury by decreasing ROS production. Biomed. Pharmacother. 2019, 115, 108914. [Google Scholar] [CrossRef]
  20. Frijhoff, J.; Winyard, P.G.; Zarkovic, N.; Davies, S.S.; Stocker, R.; Cheng, D.; Knight, A.R.; Taylor, E.L.; Oettrich, J.; Ruskovska, T.; et al. Clinical Relevance of Biomarkers of Oxidative Stress. Antioxid. Redox Signal. 2015, 23, 1144–1170. [Google Scholar] [CrossRef] [Green Version]
  21. Bhushan, B.; Michalopoulos, G.K. Role of epidermal growth factor receptor in liver injury and lipid metabolism: Emerging new roles for an old receptor. Chem. Biol. Interact. 2020, 324, 109090. [Google Scholar] [CrossRef] [PubMed]
  22. Chen, H.; Zhou, C.; Xie, K.; Meng, X.; Wang, Y.; Yu, Y. Hydrogen-rich Saline Alleviated the Hyperpathia and Microglia Activation via Autophagy Mediated Inflammasome Inactivation in Neuropathic Pain Rats. Neuroscience 2019, 421, 17–30. [Google Scholar] [CrossRef]
  23. Moon, D.H.; Kang, D.Y.; Haam, S.J.; Yumoto, T.; Tsukahara, K.; Yamada, T.; Nakao, A.; Lee, S. Hydrogen gas inhalation ameliorates lung injury after hemorrhagic shock and resuscitation. J. Thorac. Dis. 2019, 11, 1519–1527. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  24. Zheng, H.; Yu, Y.S. Chronic hydrogen-rich saline treatment attenuates vascular dysfunction in spontaneous hypertensive rats. Biochem. Pharmacol. 2012, 83, 1269–1277. [Google Scholar] [CrossRef] [PubMed]
  25. Bai, G.; Li, H.; Ge, Y.; Zhang, Q.; Zhang, J.; Chen, M.; Liu, T.; Wang, H. Influence of Hydrogen-rich Saline on Hepatocyte Autophagy During Laparoscopic Liver Ischaemia-reperfusion Combined Resection Injury in Miniature Pigs. J. Vet. Res. 2018, 62, 395–403. [Google Scholar] [CrossRef] [Green Version]
  26. Gao, C.Y.; Tian, C.R.; Zhou, R.; Zhang, R.G.; Lu, Y.H. Phenolic composition, DNA damage protective activity and hepatoprotective effect of free phenolic extract from Sphallerocarpus gracilis seeds. Int. Immunopharmacol. 2014, 20, 238–247. [Google Scholar] [CrossRef] [PubMed]
  27. Zhou, Y.; Cai, T.; Xu, J.; Jiang, L.; Wu, J.; Sun, Q.; Zen, K.; Yang, J. UCP2 attenuates apoptosis of tubular epithelial cells in renal ischemia-reperfusion injury. Am. J. Physiol. Renal Physiol. 2017, 313, F926–F937. [Google Scholar] [CrossRef]
  28. Ding, Y.; Zheng, Y.; Huang, J.; Peng, W.; Chen, X.; Kang, X.; Zeng, Q. UCP2 ameliorates mitochondrial dysfunction, inflammation, and oxidative stress in lipopolysaccharide-induced acute kidney injury. Int. Immunopharmacol. 2019, 71, 336–349. [Google Scholar] [CrossRef] [PubMed]
  29. Zhou, M.C.; Yu, P.; Sun, Q.; Li, Y.X. Expression profiling analysis: Uncoupling protein 2 deficiency improves hepatic glucose, lipid profiles and insulin sensitivity in high-fat diet-fed mice by modulating expression of genes in peroxisome proliferator-activated receptor signaling pathway. J. Diabetes Investig. 2016, 7, 179–189. [Google Scholar] [CrossRef] [Green Version]
  30. Mo, J.; Enkhjargal, B.; Travis, Z.D.; Zhou, K.; Wu, P.; Zhang, G.; Zhu, Q.; Zhang, T.; Peng, J.; Xu, W.; et al. AVE 0991 attenuates oxidative stress and neuronal apoptosis via Mas/PKA/CREB/UCP-2 pathway after subarachnoid hemorrhage in rats. Redox Biol. 2019, 20, 75–86. [Google Scholar] [CrossRef]
  31. Hass, D.T.; Barnstable, C.J. Uncoupling proteins in the mitochondrial defense against oxidative stress. Prog. Retin. Eye Res. 2021, 83, 100941. [Google Scholar] [CrossRef] [PubMed]
  32. Toda, C.; Diano, S. Mitochondrial UCP2 in the central regulation of metabolism. Best Pract. Res. Clin. Endocrinol. Metab. 2014, 28, 757–764. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Changes of liver injury index in serum: (a) alanine aminotransferase (ALT) level; (b) aspartate aminotransferase (AST) level. N = 8, * p < 0.05.
Figure 1. Changes of liver injury index in serum: (a) alanine aminotransferase (ALT) level; (b) aspartate aminotransferase (AST) level. N = 8, * p < 0.05.
Antioxidants 10 01933 g001
Figure 2. Change in interleukin-6 (IL-6) in livers. N = 8, * p < 0.05.
Figure 2. Change in interleukin-6 (IL-6) in livers. N = 8, * p < 0.05.
Antioxidants 10 01933 g002
Figure 3. Hematoxylin and eosin (H&E) staining of a paraffin section of liver tissue. (a,b) Liver tissue of control group rats. Hepatic lobule structure was normal. (c,d) Liver tissue of CCl4 group rats. Hepatic lobule disorder with reduced or absent hepatic sinuses. Vacuolar structures could be seen in liver cells. (e,f) Liver tissue of CCl4 + H2 group rats. The hepatic lobule structure was basically normal, and no vacuolar structure was found in the liver cells. (g,h) Liver tissue of H2 group rats. Hepatic lobule structure was normal. (a,c,e,g) Fields of vision at 40× magnification. (b,d,f,h) Higher magnifications of the area outlined in (a,c,e,g). The long scale bar refers to 100 μm. The short scale bar refers to 50 μm.
Figure 3. Hematoxylin and eosin (H&E) staining of a paraffin section of liver tissue. (a,b) Liver tissue of control group rats. Hepatic lobule structure was normal. (c,d) Liver tissue of CCl4 group rats. Hepatic lobule disorder with reduced or absent hepatic sinuses. Vacuolar structures could be seen in liver cells. (e,f) Liver tissue of CCl4 + H2 group rats. The hepatic lobule structure was basically normal, and no vacuolar structure was found in the liver cells. (g,h) Liver tissue of H2 group rats. Hepatic lobule structure was normal. (a,c,e,g) Fields of vision at 40× magnification. (b,d,f,h) Higher magnifications of the area outlined in (a,c,e,g). The long scale bar refers to 100 μm. The short scale bar refers to 50 μm.
Antioxidants 10 01933 g003
Figure 4. Nonalcoholic steatohepatitis (NASH) activity score. N = 8, * p < 0.05.
Figure 4. Nonalcoholic steatohepatitis (NASH) activity score. N = 8, * p < 0.05.
Antioxidants 10 01933 g004
Figure 5. Oil red O (ORO) staining of a frozen section of liver tissue. (a,b) Liver tissue of control group rats. No red droplet was observed in liver cells. (c,d) Liver tissue of CCl4 group rats. There were a large number of red droplet deposits in the liver cells, mostly clustered around the portal area. (e,f) Liver tissue of CCl4 + H2 group rats. There were few red droplets in liver cells. (g,h) Liver tissue of H2 group rats. No red droplet was observed in liver cells. (a,c,e,g) Fields of vision at 40× magnification. (b,d,f,h) Higher magnifications of the area outlined in (a,c,e,g). The long scale bar refers to 100 μm. The short scale bar refers to 50 μm.
Figure 5. Oil red O (ORO) staining of a frozen section of liver tissue. (a,b) Liver tissue of control group rats. No red droplet was observed in liver cells. (c,d) Liver tissue of CCl4 group rats. There were a large number of red droplet deposits in the liver cells, mostly clustered around the portal area. (e,f) Liver tissue of CCl4 + H2 group rats. There were few red droplets in liver cells. (g,h) Liver tissue of H2 group rats. No red droplet was observed in liver cells. (a,c,e,g) Fields of vision at 40× magnification. (b,d,f,h) Higher magnifications of the area outlined in (a,c,e,g). The long scale bar refers to 100 μm. The short scale bar refers to 50 μm.
Antioxidants 10 01933 g005
Figure 6. ORO positive area rate. N = 8, * p < 0.05.
Figure 6. ORO positive area rate. N = 8, * p < 0.05.
Antioxidants 10 01933 g006
Figure 7. Changes in the expression of oxidative stress-related factors. (a) Change in malondialdehyde (MDA) in livers. (b) Change in superoxide dismutase (SOD) in livers. N = 8, * p < 0.05.
Figure 7. Changes in the expression of oxidative stress-related factors. (a) Change in malondialdehyde (MDA) in livers. (b) Change in superoxide dismutase (SOD) in livers. N = 8, * p < 0.05.
Antioxidants 10 01933 g007
Figure 8. Changes in the expression of uncoupling protein 2 (UCP2) were observed by immunohistochemistry. (a,b) The expression of UCP2 in liver tissue of control group rats. A small number of UCP2-positive cells were brownish yellow in the cytoplasm. (c,d) The expression of UCP2 in liver tissue of CCl4 group rats. A small number of UCP2 positive cells were brownish yellow in the cytoplasm. (e,f) The expression of UCP2 in liver tissue of CCl4 + H2 group rats. UCP2 was diffusely expressed in liver cells, and the staining sites were mostly located on the cell membrane. (g,h) The expression of UCP2 in liver tissue of H2 group rats. The number of UCP2 positive cells with brownish-yellow staining in the cytoplasm increased significantly. (a,c,e,g) Fields of vision at 40× magnification. (b,d,f,h) Higher magnifications of the area outlined in (a,c,e,g). The long scale bar refers to 100 μm. The short scale bar refers to 50 μm.
Figure 8. Changes in the expression of uncoupling protein 2 (UCP2) were observed by immunohistochemistry. (a,b) The expression of UCP2 in liver tissue of control group rats. A small number of UCP2-positive cells were brownish yellow in the cytoplasm. (c,d) The expression of UCP2 in liver tissue of CCl4 group rats. A small number of UCP2 positive cells were brownish yellow in the cytoplasm. (e,f) The expression of UCP2 in liver tissue of CCl4 + H2 group rats. UCP2 was diffusely expressed in liver cells, and the staining sites were mostly located on the cell membrane. (g,h) The expression of UCP2 in liver tissue of H2 group rats. The number of UCP2 positive cells with brownish-yellow staining in the cytoplasm increased significantly. (a,c,e,g) Fields of vision at 40× magnification. (b,d,f,h) Higher magnifications of the area outlined in (a,c,e,g). The long scale bar refers to 100 μm. The short scale bar refers to 50 μm.
Antioxidants 10 01933 g008
Figure 9. UCP2-positive area rate. N = 8, * p < 0.05.
Figure 9. UCP2-positive area rate. N = 8, * p < 0.05.
Antioxidants 10 01933 g009
Figure 10. Expression changes of UCP2 (Western blotting). (a) Representative western blotting image of UCP2. (b) Statistical results of western blotting. N = 8, * p < 0.05.
Figure 10. Expression changes of UCP2 (Western blotting). (a) Representative western blotting image of UCP2. (b) Statistical results of western blotting. N = 8, * p < 0.05.
Antioxidants 10 01933 g010
Table 1. Statistical data of serum ALT and AST.
Table 1. Statistical data of serum ALT and AST.
ControlCCl4CCl4 + H2H2
ALT (U/L)36.25 ± 1.08121.50 ± 3.37 *75.00 ± 6.11 #34.75 ± 0.88
AST (U/L)91.43 ± 1.1199.88 ± 1.41 *88.41 ± 2.89 #93.88 ± 0.70
* p < 0.05 vs. control group. # p < 0.05 vs. CCl4 group.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Wang, J.; Cheng, Q.; Fang, J.; Ding, H.; Liu, H.; Fang, X.; Chen, C.; Zhang, W. A Preliminary Study on the Effect of Hydrogen Gas on Alleviating Early CCl4-Induced Chronic Liver Injury in Rats. Antioxidants 2021, 10, 1933. https://doi.org/10.3390/antiox10121933

AMA Style

Wang J, Cheng Q, Fang J, Ding H, Liu H, Fang X, Chen C, Zhang W. A Preliminary Study on the Effect of Hydrogen Gas on Alleviating Early CCl4-Induced Chronic Liver Injury in Rats. Antioxidants. 2021; 10(12):1933. https://doi.org/10.3390/antiox10121933

Chicago/Turabian Style

Wang, Jianwei, Quancheng Cheng, Jinyu Fang, Huiru Ding, Huaicun Liu, Xuan Fang, Chunhua Chen, and Weiguang Zhang. 2021. "A Preliminary Study on the Effect of Hydrogen Gas on Alleviating Early CCl4-Induced Chronic Liver Injury in Rats" Antioxidants 10, no. 12: 1933. https://doi.org/10.3390/antiox10121933

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop